139 related articles for article (PubMed ID: 18347145)
1. Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice.
Alferez D; Wilkinson RW; Watkins J; Poulsom R; Mandir N; Wedge SR; Pyrah IT; Smith NR; Jackson L; Ryan AJ; Goodlad RA
Mol Cancer Ther; 2008 Mar; 7(3):590-8. PubMed ID: 18347145
[TBL] [Abstract][Full Text] [Related]
2. Effects of vandetanib on adenoma formation in a dextran sodium sulphate enhanced Apc(MIN/+) mouse model.
Alferez DG; Ryan AJ; Goodlad RA; Wright NA; Wilkinson RW
Int J Oncol; 2010 Oct; 37(4):767-72. PubMed ID: 20811697
[TBL] [Abstract][Full Text] [Related]
3. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans.
Bongers G; Muniz LR; Pacer ME; Iuga AC; Thirunarayanan N; Slinger E; Smit MJ; Reddy EP; Mayer L; Furtado GC; Harpaz N; Lira SA
Gastroenterology; 2012 Sep; 143(3):730-740. PubMed ID: 22643351
[TBL] [Abstract][Full Text] [Related]
4. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
Goodlad RA; Ryan AJ; Wedge SR; Pyrah IT; Alferez D; Poulsom R; Smith NR; Mandir N; Watkins AJ; Wilkinson RW
Carcinogenesis; 2006 Oct; 27(10):2133-9. PubMed ID: 16782971
[TBL] [Abstract][Full Text] [Related]
6. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse.
Shaw PH; Maughan TS; Clarke AR
Br J Cancer; 2011 Aug; 105(5):649-57. PubMed ID: 21811251
[TBL] [Abstract][Full Text] [Related]
8. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
Moran AE; Hunt DH; Javid SH; Redston M; Carothers AM; Bertagnolli MM
J Biol Chem; 2004 Oct; 279(41):43261-72. PubMed ID: 15294912
[TBL] [Abstract][Full Text] [Related]
9. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
10. The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine.
Lin S; Lee SJ; Shim H; Chun J; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1128-38. PubMed ID: 20724530
[TBL] [Abstract][Full Text] [Related]
11. Deoxycholic acid activates epidermal growth factor receptor and promotes intestinal carcinogenesis by ADAM17-dependent ligand release.
Dong W; Liu L; Dou Y; Xu M; Liu T; Wang S; Zhang Y; Deng B; Wang B; Cao H
J Cell Mol Med; 2018 Sep; 22(9):4263-4273. PubMed ID: 29956475
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous deletion of ATG5 in Apc(Min/+) mice promotes intestinal adenoma growth and enhances the antitumor efficacy of interferon-gamma.
Wang L; Wang Y; Lu Y; Zhang Q; Qu X
Cancer Biol Ther; 2015; 16(3):383-91. PubMed ID: 25695667
[TBL] [Abstract][Full Text] [Related]
13. Plant stanols induce intestinal tumor formation by up-regulating Wnt and EGFR signaling in Apc Min mice.
Marttinen M; Päivärinta E; Storvik M; Huikko L; Luoma-Halkola H; Piironen V; Pajari AM; Mutanen M
J Nutr Biochem; 2013 Jan; 24(1):343-52. PubMed ID: 22981369
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice.
Korsisaari N; Kasman IM; Forrest WF; Pal N; Bai W; Fuh G; Peale FV; Smits R; Ferrara N
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10625-30. PubMed ID: 17553957
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.
Blanc V; Henderson JO; Newberry RD; Xie Y; Cho SJ; Newberry EP; Kennedy S; Rubin DC; Wang HL; Luo J; Davidson NO
Cancer Res; 2007 Sep; 67(18):8565-73. PubMed ID: 17875695
[TBL] [Abstract][Full Text] [Related]
17. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
[TBL] [Abstract][Full Text] [Related]
19. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
